Paying users zone. Data is hidden behind 
.
Get 1-month access to Walgreens Boots Alliance Inc. for $15.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Walgreens Boots Alliance Inc. (WBA)
Enterprise Value to EBITDA (EV/EBITDA)
Intermediate level
Earnings before Interest, Tax, Depreciation and Amortization (EBITDA)
Walgreens Boots Alliance Inc., EBITDA calculation
US$ in millions
Based on: 10-K (filing date: 2019-10-28), 10-K (filing date: 2018-10-11), 10-K (filing date: 2017-10-25), 10-K (filing date: 2016-10-20), 10-K (filing date: 2015-10-28), 10-K (filing date: 2014-10-20).
| Item | Description | The company |
|---|---|---|
| EBITDA | To calculate EBITDA analysts start with net earnings. To that earnings number, interest, taxes, depreciation, and amortization are added. EBITDA as a pre-interest number is a flow to all providers of capital. | Walgreens Boots Alliance Inc.’s EBITDA increased from 2017 to 2018 but then slightly decreased from 2018 to 2019 not reaching 2017 level. |
Enterprise Value to EBITDA Ratio, Current
Walgreens Boots Alliance Inc., current EV/EBITDA calculation, comparison to benchmarks
| Selected Financial Data (US$ in millions) | |
| Enterprise value (EV) | |
| Earnings before interest, tax, depreciation and amortization (EBITDA) | |
| Valuation Ratio | |
| EV/EBITDA | |
| Benchmarks | |
| EV/EBITDA, Competitors1 | |
| CVS Health Corp. | |
| EV/EBITDA, Sector | |
| Food & Drug Retailers | |
| EV/EBITDA, Industry | |
| Consumer Services | |
Based on: 10-K (filing date: 2019-10-28).
1 Click competitor name to see calculations.
If the company EV/EBITDA is lower then the EV/EBITDA of benchmark then company is relatively undervalued.
Otherwise, if the company EV/EBITDA is higher then the EV/EBITDA of benchmark then company is relatively overvalued.
Enterprise Value to EBITDA Ratio, Historical
Walgreens Boots Alliance Inc., historical EV/EBITDA calculation, comparison to benchmarks
| Aug 31, 2019 | Aug 31, 2018 | Aug 31, 2017 | Aug 31, 2016 | Aug 31, 2015 | Aug 31, 2014 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||
| Enterprise value (EV)1 | |
|
|
|
|
|
|
| Earnings before interest, tax, depreciation and amortization (EBITDA)2 | |
|
|
|
|
|
|
| Valuation Ratio | |||||||
| EV/EBITDA3 | |
|
|
|
|
|
|
| Benchmarks | |||||||
| EV/EBITDA, Competitors4 | |||||||
| CVS Health Corp. | |
|
|
|
|
|
|
| EV/EBITDA, Sector | |||||||
| Food & Drug Retailers | |
|
|
|
|
|
|
| EV/EBITDA, Industry | |||||||
| Consumer Services | |
|
|
|
|
|
|
Based on: 10-K (filing date: 2019-10-28), 10-K (filing date: 2018-10-11), 10-K (filing date: 2017-10-25), 10-K (filing date: 2016-10-20), 10-K (filing date: 2015-10-28), 10-K (filing date: 2014-10-20).
3 2019 Calculation
EV/EBITDA = EV ÷ EBITDA
= ÷ =
4 Click competitor name to see calculations.
| Valuation ratio | Description | The company |
|---|---|---|
| EV/EBITDA | Enterprise value to earnings before interest, tax, depreciation and amortization is a valuation indicator for the overall company rather than common stock. | Walgreens Boots Alliance Inc.’s EV/EBITDA ratio decreased from 2017 to 2018 and from 2018 to 2019. |